molecs top image

Turn your cancer patient’s NGS data into actionable insights with just a few clicks 🧬

Molecs provides cloud-based platforms by combining artificial intelligence, omics technologies, and healthcare. Our vision takes shape in the future of healthier lives.

Try Now
molecs top image

Supported by

What is Molecs?

Molecs provides cloud based platforms that turn your raw NGS data into actionable insights.

Blazingly Fast

Our fully automated analysis pipeline reduces the turnaround time from days to minutes. Plus, unlike human scientists, our platform runs 24/7/365 with 99.99% uptime.

Infinitely Scalable

There is no limit how many analysis you can run at a time. Whether it’s 1, 10 or 100, all of them run in parallel.

Easy to Use

No need for any kind of set-up. Just upload your data and start the analysis. We’ll handle the rest and notify you when the analysis is finished.

Our Products

molecs product

It is a fully automated cloud-based platform offering a clinical workflow for comprehensive genomic and transcriptomic profiling of cancer-related genes.

Mercury provides:
  • Blazingly fast, accurate, and interactive analyses based on your patients’ raw NGS data
  • A list of personalized medicine recommendations based on identified mutations and patients’ conditions
  • A list of worldwide clinical trials based on identified mutations and patient conditions
  • Mutation detection classified by biological and therapeutic impacts
molecs product

Simply, if artificial Intelligence can explain a car to drive on its own, it should be able to improve the outcomes of cancer research. We need it to be applied in the best way.

At Molecs, we believe that incorporating AI over big data is a critical component of the scientific method. Therefore, we are developing Project Jupyter to present greater clarity on cancer prognosis.

Always keeping in mind the confidentiality of patient’s data, we pursue to discover the highest success rates of a healthier life, by linking up trends in the enlarging cancer transcriptomics data. At Molecs, we desire to acquire a deeper understanding of the biological mechanisms behind patient-specific predictions.

molecs product
molecs product

Unhappily, it is still a luxury to have a bioinformatics specialist friend. Therefore, we are delivering Project 101 to our wet-lab friends.

Project 101 provides a scalable cloud environment with inbuilt NGS data analysis pipelines such as RNA-seq, scRNA-seq, ATAC-seq, and ChIP-seq, etc. with easy to learn training modules.

If you have done with your sequencer, just run it on Project 101.

molecs product

RNA-seq is exceptionally advantageous at discovering structural variants. However, for the required sensitivity of finding single nucleotide variants and indels, we have initiated Project Dust.

Project Dust is aimed to evolve into a state-of-the-art analysis pipeline that uses a deep neural network to call genetic variants from next-generation RNA sequencing data. At Molecs, we sincerely care about Project Dust to increase the accuracy of Project Mercury.

So that, precision matters.

molecs product

How It Works

Any product we develop has just three easy steps



Drag and drop your samples to upload



Choose analysis type, customize and start the analysis



Your result will be ready in minutes

Join The Team

Feel free to drop us your resume at the email below.

You can nudge us at any moment. We’d be happy to hear from you!

Or get notified when new positions are available

Latest News

molecs news hackquarters

2019 batch for Bayer’s G4A Turkey has kicked-off

Those chosen startups that we mentioned above will get 60K TL grants each. Also they will get the chance to work closely with Bayer experts and Hackquarters mentors for the next 100 days.

Read More
molecs news sabanci university

Molecs has developed a next generation RNA sequencing data analysis platform

Molecs received a total of ₺280000 grant from Bayer (Grant4Apps), Tubitak and Sabancı University. The team will use those grants to accelerate the development of their products.

Read More
molecs news bayer

Bayer's G4A acceleration program winners were announced

The 2019 winners of Bayer's accelerator program Grants4Apps which supports the health startups were announced.

Read More

Request Demo

Drop us your email address to request your free demo. One of our team members will contact you as soon as possible.

Contact Us

Use the form below to get in touch with Molecs team to schedule a demo or for general enquiries.

© Molecs 2020. All rights reserved
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.